The Effects of Anesthetics and Perioperative Medications on Immune Function: A Narrative Review

Abstract

Preclinical and clinical studies have sought to better understand the effect of anesthetic agents, both volatile and intravenous, and perioperative adjuvant medications on immune function. The immune system has evolved to incorporate both innate and adaptive components, which are delicately interwoven and essential for host defense from pathogens and malignancy. This review summarizes the complex and nuanced relationship that exists between each anesthetic agent or perioperative adjuvant medication studied and innate and adaptive immune function with resultant clinical implications. The most commonly used anesthetic agents were chosen for review including volatile agents (sevoflurane, isoflurane, desflurane, and halothane), intravenous agents (propofol, ketamine, etomidate, and dexmedetomidine), and perioperative adjuvant medications (benzodiazepines, opioids, nonsteroidal anti-inflammatory drugs [NSAIDs], and local anesthetic agents). Patients who undergo surgery experience varying combinations of the aforementioned anesthetic agents and adjuncts, depending on the type of surgery and their comorbidities. Each has unique effects on immunity, which may be more or less ideal depending on the clinical situation. Further study is needed to better understand the clinical effects of these relationships so that patient-specific strategies can be developed to improve surgical outcomes.

Perioperative Inflammatory Response and Cancer Recurrence in Lung Cancer Surgery: A Narrative Review

“…In a study of the effects of anesthetics on NK cell activity and metastasis in a breast cancer mouse model, propofol was reported as the only agent that did not suppress NK cell activity or increase metastasis ( 100 ). Other intravenous agents such as thiopental, etomidate and ketamine, also have anti-inflammatory properties ( 101 ), and thiopental and ketamine were associated with suppressed NK cell activity ( 100 ).…”

Pancreatic Cancer and Microenvironments: Implications of Anesthesia

“…However, even in malignancy without preceding inflammation, cancer-induced inflammation, secretions of inflammatory factors, and immune cell infiltration are main characters in tumor initiation and advanced metastasis [ 118 ]. Anesthesia and analgesia may impact cellular immunity and inflammation during surgery, and thus affect cancer outcomes [ 119 , 120 , 121 , 122 , 123 , 124 , 125 ].…”

Cancer Immunotherapies: What the Perioperative Physician Needs to Know

“…The immune system consists of deeply connected and interrelated cellular networks and signaling for both non-specific and acquired cellular defenses (Fig. 1) [4]. Targeting cells, ligands, signaling This article is part of the Topical Collection on Anesthesiology and Critical Care molecules, and cytokines has become increasingly effective as cancer immunotherapeutics were applied to more and more patients [5].…”